Thymosin alpha-1: approved abroad, investigational in the US
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
Thymosin alpha-1 (Zadaxin) is an interesting case because it is approved or registered in several countries for indications like chronic hepatitis B and as an immune adjuvant, but it remains not FDA approved in the United States.
The human evidence is genuinely mixed and very indication-dependent. It is more substantiated than the pure research peptides for some uses, but the US regulatory status and the heterogeneity of the trials are both worth keeping in mind.
3